Navigation Links
STD Med Inc. Receives ANVISA Registration for Class III Medical Devices in Brazil
Date:11/8/2012

STOUGHTON, Mass., Nov. 8, 2012 /PRNewswire/ -- STD Med, Inc. is pleased to announce that it has received a Certificate of Good Practices for Manufacturing of Class III Medical Devices from ANVISA, the Brazilian National Surveillance Agency (Agencia Nacional de Vigilancia Sanitaria –ANVISA). All medical devices must be registered with ANVISA before being sold in Brazil. The Certificate of Good Practices was granted after an intensive audit by the Brazilian agency of STD Med's manufacturing facilities. Currently this audit has a 2 to 3 year wait list and is one of the primary hurdles for new medical device product registration in Brazil.

Steven Tallarida, President of STD Med Inc. stated, "STD Med is one of the best middle market medical device manufacturers in the business and we look forward to bringing U.S. quality medical products into the South American healthcare system."  Rafael Martinelli de Oliveira, President of BMR Medical, a Brazilian medical device commercialization and distribution company also added, "STD Med has been a manufacturing partner since 2006 and has always provided us with outstanding service and high quality products. They understand the Brazilian market and their willingness and ability to meet local requirements has always been a top priority. A result of this commitment to the Brazilian market is ANVISA GMP certification, which will allow us to launch new products faster and more efficiently."

SyncMedical LLC, a subsidiary of STD Med Inc., is uniquely positioned to further assist in establishing emerging new technologies in Brazil. With a distribution network of 13 offices in Brazil, SyncMedical has the ability to establish sales and marketing support in the Brazilian medical device market for any U.S. based company looking to launch their products into Brazil and Latin America.

As an approved manufacturer, STD Med can now provide their clients with the needed documentation to significantly shorten the regulatory approval process in Brazil. With a population of over 250 million people, Brazil's medical device market is in the top ten globally and with ANVISA certification, STD Med is poised to become a major producer of quality medical device products for the Brazilian marketplace. The addition of the ANVISA approval continues to identify STD Med, Inc.  as a leading medical device company serving customers throughout the world.

About  STD Med, Inc.

STD Med, Inc. is a rapidly growing and emerging leader in the development and manufacture of medical devices and precision machined components. Established in 1953, STD Med, Inc. is a privately held company with 3 facilities in Massachusetts which are ISO 13485:2003, ISO 9001:2008, JPAL and FDA approved. Over the past several years STD Med, Inc. has incubated and invested in several new technologies including Angiolink Corporation (acquired by Medtronic), Arthrosurface Inc., Spirus Medical, Inc.(acquired by Olympus) and Cardiosolutions, Inc. and it is our intention to continue to pursue disruptive innovation in the medical device marketplace.


'/>"/>
SOURCE STD Med
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. PAREXEL Chief Operating Officer Dr. Mark A. Goldberg Receives Special Recognition Award
2. Leica Biosystems Receives FDA Approval for the Fully Automated Bond Oracle™ HER2 IHC System on the Leica BOND-MAX
3. Nephros Receives 510(k) Clearance for Hemodiafiltration System
4. ProUroCare Medical Receives FDA Clearance for ProUroScan Elasticity Imaging System
5. BONESUPPORT Receives Red Herring 2012 Top 100 Europe Award
6. Diabecline Antibiotic Receives Edison Award for Best New Pharmaceutical Product
7. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
8. Alexza Receives Complete Response Letter for Adasuve™ NDA
9. Ventana Receives FDA Clearance for p53 (DO-7) Image Analysis and Digital Read Applications
10. Marshall Edwards Receives $4 Million Subscription From Novogen In Rights Offering
11. New Chronic Wound Treatment Device Receives Award from Veterans Healthcare Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2017)... 29, 2017  Cellect Biotechnology Ltd. (NASDAQ: ... enables the functional selection of stem cells, today provided ... first quarter ended March 31 st , 2017. ... in the first quarter of 2017," said Dr. Shai ... announced the treatment of the first blood cancer patient ...
(Date:5/26/2017)... SANTA BARBARA, Calif. , May 25, 2017 /PRNewswire-USNewswire/ ... the United States , Direct Relief is working ... of overdose-reversing Naloxone available at no cost to community ... and other nonprofit providers nationwide. "Pfizer ... expanding access to medicines and ensuring patient safety through ...
(Date:5/23/2017)... , May 23, 2017  Leaf Healthcare, recognized ... medical devices for pressure ulcer prevention, will unveil ... Association of Critical Care Nurses, National Teaching Institute ... The Leaf Patient Monitoring System is ... the hospital environment.  The system seamlessly tracks patient ...
Breaking Medicine Technology:
(Date:6/23/2017)... (PRWEB) , ... June 23, 2017 , ... All-Star Insurance, ... residential and business clients throughout eastern Texas, is announcing the launch of a new ... Recent breast cancer statistics in the United States reveal that an estimated 252, 710 ...
(Date:6/22/2017)... ... June 22, 2017 , ... United Benefit Advisors (UBA), the ... Company as its newest Partner Firm. Headquartered in Coconut Creek, Florida, Whipple & ... tailoring optimized benefit packages that strengthen the relationship between employer and employee. , ...
(Date:6/22/2017)... ... June 22, 2017 , ... ... that it has received certification for ANSI/ASIS PSC.1-2012. The company’s work in countries ... where the rule of law has been degraded. The PSC.1 standard was created ...
(Date:6/20/2017)... ... 2017 , ... United Benefit Advisors (UBA), the nation’s leading ... you-bee) for 2017. The award honors Partner Firms, Principals, agency staff, and ... clients they serve, and the benefits insurance industry as a whole. , “The ...
(Date:6/20/2017)... ... 20, 2017 , ... Kenneth Mayer, MD, has been appointed a new Editor-in-Chief ... who joined the JIAS Editorial Board in 2016, has co-authored more than 800 peer-reviewed ... Fenway Health and Co-Chair of The Fenway Institute, a member of the US ...
Breaking Medicine News(10 mins):